<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00250406</url>
  </required_header>
  <id_info>
    <org_study_id>R-05-646</org_study_id>
    <nct_id>NCT00250406</nct_id>
  </id_info>
  <brief_title>Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation</brief_title>
  <official_title>Assessment of Bacterial Adherence and Biofilm Formation on a Triclosan Loaded Ureteral Stent: A Phase II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the clinical effects of a triclosan stent on
      adherent bacteria, stent biofilms, and patient urine cultures in patients with an indwelling
      triclosan ureteral stent. The patient populations that will be tested include: patients
      following ureteroscopy and patients scheduled to undergo shockwave lithotripsy who require a
      ureteral stent. It is hypothesized that triclosan eluting ureteral stents will reduce the
      number of bacteria both on (within biofilm) and around (in the urine) a ureteral stent.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary objective is to determine if the number of stent adherent bacteria will be less in patients who receive a triclosan stent compared to a control/standard stent.</measure>
    <time_frame>at time of intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary objectives to be assessed include the amount of biofilm adherent to each stent and each patient's urine culture.</measure>
    <time_frame>at time of intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Renal Calculi</condition>
  <condition>Ureteral Obstruction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Percuflex Plus Ureteral Stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TRIUMPH stent (triclosan-eluting stent)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ureteral Stent</intervention_name>
    <description>triclosan-eluting ureteral stent</description>
    <arm_group_label>2</arm_group_label>
    <other_name>TRIUMPH STENT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ureteral Stent</intervention_name>
    <description>Percuflex Plus Stent as the control</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Percuflex Plus Stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who undergo ureteroscopy for any reason and require a ureteral stent
             post-operatively as determined by the surgeon (e.g. renal obstruction, ureteral edema,
             ureteral perforation, large stone fragments to pass, following ureteral dilation,
             ureteral trauma, solitary kidney, or any other reason left to the discretion of the
             surgeon).

          -  Patients undergoing extracorporeal shockwave lithotripsy (ESWL) who will require a
             stent as determined by the treating urologist (e.g. solitary kidney, ureteral stone &gt;
             1 cm, renal stone &gt; 1.5 cm, significant renal obstruction, history of pyelonephritis,
             or any other reason left to the discretion of the surgeon).

          -  Patients who have or are going to have chronic ureteral stents, for any reason.

          -  Patients willing to return to St. Joseph's Hospital's Urology Clinic for follow-up.

        Exclusion Criteria:

          -  Age â‰¤ 17 years

          -  Patients unable to consent.

          -  Any patient requiring endocarditis or prosthetic device prophylaxis (e.g. fresh
             arthroplasty etc.).

          -  Pregnant females

          -  Immunocompromised patients

          -  Significant urinary symptoms (urgency, dysuria, strangury, hematuria) or other bladder
             pathology that may cause these symptoms (e.g. interstitial cystitis)

          -  Anyone in the investigator's opinion that would be unsuitable.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John D Denstedt, MD, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Joseph's Hospital, The University of Western Ontario</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology, St. Joseph's Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2005</study_first_submitted>
  <study_first_submitted_qc>November 4, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2005</study_first_posted>
  <last_update_submitted>December 19, 2013</last_update_submitted>
  <last_update_submitted_qc>December 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>John Denstedt</investigator_full_name>
    <investigator_title>Chair/Chief, Department of Surgery, Western University</investigator_title>
  </responsible_party>
  <keyword>urolithiasis</keyword>
  <keyword>ureteral stent</keyword>
  <keyword>triclosan</keyword>
  <keyword>drug eluting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Ureteral Obstruction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triclosan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

